Anthony Petrone's Stock Ratings

Mizuho Analyst

Anthony Petrone is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

6.70%

Smart Score

64.1%

Overall Average Return Percentile

53rd

Number of Ratings

123
Buy NowGet Alert
05/15/2024ALCBuy Now
Alcon
$89.0017.98%$100 → $105MaintainsBuyGet Alert
05/15/2024BSXBuy Now
Boston Scientific
$75.5719.09%$85 → $90MaintainsBuyGet Alert
05/10/2024ADMABuy Now
ADMA Biologics
$9.5026.32%$10 → $12MaintainsBuyGet Alert
05/08/2024STAABuy Now
Staar Surgical
$41.5332.43%$53 → $55MaintainsBuyGet Alert
05/03/2024LNTHBuy Now
Lantheus Holdings
$81.8322.2%$90 → $100MaintainsBuyGet Alert
05/02/2024LIVNBuy Now
LivaNova
$61.0731%$75 → $80MaintainsBuyGet Alert
05/01/2024GEHCBuy Now
GE HealthCare Techs
$78.0034.62%$110 → $105MaintainsBuyGet Alert
04/25/2024BSXBuy Now
Boston Scientific
$75.5712.48%$80 → $85MaintainsBuyGet Alert
04/11/2024GEHCBuy Now
GE HealthCare Techs
$78.0041.03%$96 → $110MaintainsBuyGet Alert
04/11/2024STAABuy Now
Staar Surgical
$41.5327.62%$45 → $53MaintainsBuyGet Alert
04/11/2024NVROBuy Now
Nevro
$9.3571.12%$20 → $16MaintainsNeutralGet Alert
04/11/2024GKOSBuy Now
Glaukos
$112.72-11.28%$85 → $100MaintainsNeutralGet Alert
04/11/2024EWBuy Now
Edwards Lifesciences
$86.8920.84%$95 → $105MaintainsBuyGet Alert
04/01/2024ESTABuy Now
Establishment Labs Hldgs
$52.2324.45%$50 → $65ReiteratesBuy → BuyGet Alert
03/27/2024RMDBuy Now
ResMed
$206.334.2%$215 → $215MaintainsBuyGet Alert
03/27/2024LIVNBuy Now
LivaNova
$61.0722.81%$75 → $75MaintainsBuyGet Alert
03/27/2024INSPBuy Now
Inspire Medical Systems
$158.7957.44%$250 → $250MaintainsBuyGet Alert
03/06/2024TARSBuy Now
Tarsus Pharmaceuticals
$32.9633.5%$30 → $44MaintainsBuyGet Alert
03/01/2024COOBuy Now
Cooper Companies
$94.3121.94%$102.5 → $115MaintainsBuyGet Alert
03/01/2024MDXGBuy Now
MiMedx Group
$7.1595.8%$13 → $14MaintainsBuyGet Alert
03/01/2024ALCBuy Now
Alcon
$89.0012.36%$95 → $100MaintainsBuyGet Alert
03/01/2024ADMABuy Now
ADMA Biologics
$9.505.26%$9 → $10MaintainsBuyGet Alert
02/28/2024STAABuy Now
Staar Surgical
$41.538.36%$50 → $45MaintainsBuyGet Alert
02/22/2024LIVNBuy Now
LivaNova
$61.0722.81%$70 → $75MaintainsBuyGet Alert
02/21/2024MDTBuy Now
Medtronic
$81.3720.44%$95 → $98MaintainsBuyGet Alert
02/20/2024LIVNBuy Now
LivaNova
$61.0714.62%$60 → $70UpgradeNeutral → BuyGet Alert
02/07/2024INSPBuy Now
Inspire Medical Systems
$158.7957.44%$225 → $250MaintainsBuyGet Alert
02/07/2024GEHCBuy Now
GE HealthCare Techs
$78.0023.08%$94 → $96MaintainsBuyGet Alert
02/07/2024EWBuy Now
Edwards Lifesciences
$86.899.33%$85 → $95MaintainsBuyGet Alert
02/01/2024BSXBuy Now
Boston Scientific
$75.575.86% → $80UpgradeNeutral → BuyGet Alert

Recent Analyst Stock Rating News

Expert Ratings For GE HealthCare Techs
What Analysts Are Saying About Edwards Lifesciences Stock
Assessing Cooper Companies: Insights From 7 Financial Analysts
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
The Analyst Landscape: 5 Takes On Establishment Labs Hldgs
Boston Scientific's Upside With Cardiology Devices Drives Momentum
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.
Decoding 18 Analyst Evaluations For Boston Scientific
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
Analyst Ratings For Tarsus Pharmaceuticals
Assessing Nevro: Insights From 9 Financial Analysts
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free